A phase II randomized, double-blind, placebo-controlled multicenter trial evaluating the efficacy and safety of enzalutamide in combination with exemestane in estrogen or progesterone receptor-positive and HER2-normal advanced breast cancer.
Denise A. Yardley
No relevant relationships to disclose
Ahmad Awada
No relevant relationships to disclose
Javier Cortes
Consultant or Advisory Role - Celgene; Novartis; Roche
Honoraria - Celgene; Eisai; Novartis; Roche
Howard A. Burris
No relevant relationships to disclose
Amy C. Peterson
Employment or Leadership Position - Medivation
Consultant or Advisory Role - Medivation
Iulia Cristina Tudor
Employment or Leadership Position - Medivation
Stock Ownership - Medivation
Shanna Stopatschinskaja
Employment or Leadership Position - Medivation
Joyce Leta Steinberg
Employment or Leadership Position - Astellas Pharma
Luca Gianni
Consultant or Advisory Role - AstraZeneca; BioScience; Boehringer Ingelheim; Celgene; Genentech; GlaxoSmithKline; Novartis; Pfizer; Roche; Taiho Pharmaceutical
Kathy D. Miller
No relevant relationships to disclose
Eric P. Winer
No relevant relationships to disclose